Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Walking the path of treatable traits in interstitial lung diseases
Francesco Amati, Paolo Spagnolo, Christopher J. Ryerson, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Prevalence and Predictors of Response to Antifibrotics in Long-Term Survivors with Idiopathic Pulmonary Fibrosis
Elisabetta Cocconcelli, Nicol Bernardinello, Paolo Cameli, et al.
Lung (2025) Vol. 203, Iss. 1
Closed Access
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
Stefano Kette, Nicolò Reccardini, Francesco Salton, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 411-411
Open Access
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion
Francesco Amati, Dean L. Kellogg, Marcos I. Restrepo, et al.
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
The global burden of heart failure attributable to interstitial lung diseases: insights from the global burden of disease study 2021
Ruiling Lu, Qin Huang, Tiantian Yu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases
Francesco Amati, Anna Stainer, Giacomo Maruca, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1047-1047
Open Access | Times Cited: 1
Use of Mycophenolate mofetil for the treatment of fibrotic hypersensitivity pneumonitis
Ana Casal, Juan Suárez‐Antelo, Francisco Gudé, et al.
The American Journal of the Medical Sciences (2024)
Closed Access | Times Cited: 1
Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg)
Ekaterina Krauss, Silke Tello, Jennifer Naumann, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Response to: are there over 200 distinct types of interstitial lung diseases?
Francesco Amati, Anna Stainer, Stefano Aliberti
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access
Are there over 200 distinct types of interstitial lung diseases?
J. Cooley, Evans R. Fernández Pérez
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender and immune-associated specific implications
Fabio Massimo Perrotta, Donato Lacedonia, Vito D’Agnano, et al.
Research Square (Research Square) (2024)
Open Access
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications
Fabio Massimo Perrotta, Donato Lacedonia, Vito D’Agnano, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top